Related Experiment Videos
Use of calcium antagonists as monotherapy in the management of hypertension
Insights
Calcium channel blockers offer a promising approach to managing hypertension by targeting vascular resistance. They may become a preferred first-line treatment for older individuals and those with low-renin hypertension.
Area of Science:
- Cardiovascular Pharmacology
- Hypertension Management
- Calcium Channel Modulation
Background:
- Hypertension treatment often relies on trial-and-error drug selection.
- Pathophysiological classification, including renin levels, offers a more targeted therapeutic approach.
- Essential hypertension is frequently linked to elevated vascular resistance.
Purpose of the Study:
- To evaluate the efficacy of calcium channel blockers in hypertension management.
- To explore the pathophysiological basis for selecting antihypertensive therapies.
- To compare calcium channel blockers with existing treatments like diuretics and beta blockers.
Main Methods:
- Investigated the role of calcium channel influx in vascular smooth muscle contraction and arterial resistance.
- Assessed vasodilatation responses to calcium channel blockers in hypertensive versus normotensive subjects.
- Correlated blood pressure reduction with patient age, baseline blood pressure, plasma epinephrine, and renin-angiotensin system activity.
Main Results:
- Calcium channel blockers produced greater vasodilatation in hypertensive patients compared to sodium nitroprusside and prazosin.
- The blood pressure-lowering effects of calcium channel blockers correlated with patient age and pretreatment blood pressure.
- These effects were inversely related to pretreatment plasma renin activity and directly related to plasma epinephrine levels.
Conclusions:
- Calcium channel blockers demonstrate significant efficacy in reducing blood pressure, particularly in hypertensive patients.
- Their effectiveness is influenced by factors such as age, baseline blood pressure, and renin-angiotensin system activity.
- Calcium entry blockers may emerge as a primary therapeutic option for specific hypertensive populations, including older adults and those with low-renin hypertension.
Abstract:
A wide variety of drug treatments are available for the management of hypertension. Often, effective therapy is found only through a process of elimination. A more pathophysiologically oriented method of choosing therapy is based on classification of patients into those with low-, normal-, and high-renin hypertension. In the past, for example, diuretics were considered to be the most effective agents for the treatment of low-renin hypertension. Most cases of essential hypertension are characterized by increased vascular resistance. Calcium channel influx is a major determinant of the free intracellular calcium concentration that finally triggers the contractile process of the vascular smooth muscle cell and thereby determines arterial resistance. In man, free calcium concentration in platelets is closely related to the height of systolic and diastolic blood pressure. Vasodilatation produced by the intra-arterial infusion of a calcium channel blocker into the forearm circulation is significantly greater in hypertensive patients than in normotensive subjects, threefold that observed with sodium nitroprusside, and fourfold that found with prazosin. In hypertensive patients, these effects are correlated directly with plasma epinephrine--reflecting sympathoadrenal activity--and inversely with the activity and reactivity of the renin-angiotensin system. In several clinical studies, the decrease in blood pressure following the administration of calcium channel entry blockers was directly correlated to the patient's age and pretreatment blood pressure, and indirectly to the pretreatment plasma renin activity. The effects of these agents are apparently also comparable to the over-all responses achievable with beta blockers and diuretics. In the future, calcium entry blockers may replace diuretics as first-line therapy for older patients and those with low-renin hypertension.